Skip to content

Nasdaq · CIK 0001823239

MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.

Insider trading from SEC Form 4. Last filing 3 d ago. Close $7.44 on Oct 9, 2026, +163% from the 52-week low and -17% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
20
with a Form 4 at this company

Price and insider trades, last year

MRVIOct 9, 2026 · close 7.44

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at MARAVAI LIFESCIENCES HOLDINGS, INC., scored.

ScoreInsiderValueHoldingsPrice contextFiled
39WeakJohn A DeFord
director
buy
$101k
17,500 shares
+33%-
56ModerateCarl Hull
See Remarks
buy
$987k
175,000 shares
--

Transactions

The last 48 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 8, 2026Bernd Brust
Chief Executive Officer
FTax withholding
Class A Common Stock
-29,250$7.43$217k1,531,9993 d ago
Sep 30, 2026Rajesh Asarpota
Chief Financial Officer
FTax withholding
Class A Common Stock
-5,465$7.65$42k418,02111 d ago
Sep 8, 2026Bernd Brust
Chief Executive Officer
FTax withholding
Class A Common Stock
-29,250$7.32$214k1,561,24933 d ago
Aug 31, 2026Rajesh Asarpota
Chief Financial Officer
FTax withholding
Class A Common Stock
-5,465$7.68$42k423,48641 d ago
Jul 15, 2025Peter Michael Leddy
See Remarks
FTax withholding
Class A Common Stock
-5,154$2.59$13k727,177Jul 16, 2025
Jul 10, 2025Gregory T Lucier
director
GGift
Class A Common Stock
-89,139$0.00$055,123Jul 11, 2025
Jul 10, 2025Gregory T Lucier
director
GGift
Class A Common Stockindirect: By Family Partnership
+89,139$0.00$0109,784Jul 11, 2025
Jun 30, 2025Rajesh Asarpota
Chief Financial Officer
AGrant or award
Class A Common Stock
+500,000--500,000Jun 30, 2025
Jun 30, 2025Rajesh Asarpota
Chief Financial Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+333,333$0.00$0333,333Jun 30, 2025
Jun 30, 2025Rajesh Asarpota
Chief Financial Officer
AGrant or award
Performance Stock Unitsderivative
+750,000$0.00$0750,000Jun 30, 2025
Jun 16, 2025R Andrew Eckert
director
AGrant or award
Class A Common Stock
+231,481$2.16$500k365,890Jun 18, 2025
Jun 16, 2025Luke Joseph Marker
director
AGrant or award
Class A Common Stock
+89,139$2.16$193k138,055Jun 18, 2025
Jun 16, 2025Murali Prahalad
director
AGrant or award
Class A Common Stock
+89,139$2.16$193k154,607Jun 18, 2025
Jun 16, 2025Constantine S Mihas
director
AGrant or award
Class A Common Stock
+89,139$2.16$193k138,055Jun 18, 2025
Jun 16, 2025Gregory T Lucier
director
AGrant or award
Class A Common Stock
+89,139$2.16$193k144,262Jun 18, 2025
Jun 16, 2025Jessica Hopfield
director
AGrant or award
Class A Common Stock
+89,139$2.16$193k199,907Jun 18, 2025
Jun 16, 2025Susannah Gray
director
AGrant or award
Class A Common Stock
+89,139$2.16$193k169,907Jun 18, 2025
Jun 16, 2025John A DeFord
director
AGrant or award
Class A Common Stock
+89,139$2.16$193k159,185Jun 18, 2025
Jun 16, 2025Benjamin James Daverman
director
AGrant or award
Class A Common Stock
+89,139$2.16$193k138,055Jun 18, 2025
Jun 16, 2025Sean Laurence Cunningham
director
AGrant or award
Class A Common Stock
+89,139$2.16$193k138,055Jun 18, 2025
Jun 8, 2025Bernd Brust
Chief Executive Officer
AGrant or award
Class A Common Stock
+2,000,000--2,000,000Jun 10, 2025
Jun 8, 2025Bernd Brust
Chief Executive Officer
AGrant or award
Employee Stock Option (Right to Buy)derivative
+1,000,000$0.00$01,000,000Jun 10, 2025
Jun 8, 2025Bernd Brust
Chief Executive Officer
AGrant or award
Performance Stock Unitsderivative
+2,250,000$0.00$02,250,000Jun 10, 2025
May 15, 2025Kevin Herde
Chief Financial Officer
AGrant or award
Class A Common Stock
+876$1.67$1,463674,636May 28, 2025
May 15, 2025Christine Dolan
See Remarks
AGrant or award
Class A Common Stock
+2,381$1.67$3,976473,607May 28, 2025
Mar 17, 2025Rebecca Buzzeo
See Remarks
FTax withholding
Class A Common Stock
-4,314$2.64$11k310,933Mar 19, 2025
Mar 17, 2025Rebecca Buzzeo
See Remarks
AGrant or award
Class A Common Stock
+295,858--606,791Mar 19, 2025
Mar 17, 2025Christine Dolan
See Remarks
FTax withholding
Class A Common Stock
-5,336$2.64$14k224,677Mar 19, 2025
Mar 17, 2025Christine Dolan
See Remarks
AGrant or award
Class A Common Stock
+246,549--471,226Mar 19, 2025
Mar 17, 2025Kevin Herde
Chief Financial Officer
FTax withholding
Class A Common Stock
-8,648$2.64$23k279,282Mar 19, 2025
Mar 17, 2025Kevin Herde
Chief Financial Officer
AGrant or award
Class A Common Stock
+394,478--673,760Mar 19, 2025
Feb 18, 2025Christine Dolan
See Remarks
FTax withholding
Class A Common Stock
-1,621$4.10$6,646230,013Feb 19, 2025
Feb 18, 2025Kevin Herde
Chief Financial Officer
FTax withholding
Class A Common Stock
-2,326$4.10$9,537287,930Feb 19, 2025
Jan 15, 2025Kevin Herde
Chief Financial Officer
FTax withholding
Class A Common Stock
-46,344$4.56$211k290,256Jan 17, 2025
Jan 15, 2025Christine Dolan
See Remarks
FTax withholding
Class A Common Stock
-28,704$4.56$131k231,634Jan 17, 2025
Jan 15, 2025Rebecca Buzzeo
See Remarks
FTax withholding
Class A Common Stock
-45,456$4.56$207k315,247Jan 17, 2025
Jan 15, 2025Andrew Burch
See Remarks
FTax withholding
Class A Common Stock
-54,412$4.56$248k369,183Jan 17, 2025
Dec 16, 2024R Andrew Eckert
director
AGrant or award
Class A Common Stock
+134,409--134,409Dec 17, 2024
Dec 9, 2024Gregory T Lucier
director
GGift
Class A Common Stock
-20,645$0.00$055,123Dec 9, 2024
Dec 9, 2024Gregory T Lucier
director
GGift
Class A Common Stockindirect: By Family Partnership
+20,645$0.00$020,645Dec 9, 2024
Nov 15, 2024Rebecca Buzzeo
See Remarks
FTax withholding
Class A Common Stock
-4,363$4.42$19k360,703Nov 18, 2024
Nov 12, 2024John A DeFord
director
POpen-market purchase
Class A Common Stock
+17,500$5.75$101k70,046Nov 14, 2024
Nov 11, 2024Carl Hull
See Remarks
POpen-market purchase
Class A Common Stockindirect: Through The Hull Living Trust
+175,000$5.64$987k175,000Nov 12, 2024
Oct 31, 2024Andrew Burch
See Remarks
AGrant or award
Class A Common Stock
+1,841$5.70$10k423,595Nov 12, 2024
Oct 31, 2024Christine Dolan
See Remarks
AGrant or award
Class A Common Stock
+1,848$5.70$11k260,338Nov 12, 2024
Oct 31, 2024Kevin Herde
Chief Financial Officer
AGrant or award
Class A Common Stock
+1,906$5.70$11k336,600Nov 12, 2024
Oct 31, 2024Kurt Oreshack
General Counsel
AGrant or award
Class A Common Stock
+366$5.70$2,086224,056Nov 12, 2024
Oct 15, 2024William E. Martin III
Chief Executive Officer
FTax withholding
Class A Common Stock
-50,843$8.29$421k989,430Oct 16, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

MRVI insider trading: MARAVAI LIFESCIENCES HOLDINGS, INC. | InsiderTell